Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, J.B. Chemicals & Pharmaceuticals has informed that it enclosed disclosure of related party transactions for the second half of the financial year 2022-23.
The above information is a part of company’s filings submitted to BSE.